InvestorsHub Logo
Followers 28
Posts 4991
Boards Moderated 0
Alias Born 01/07/2020

Re: None

Monday, 08/24/2020 4:11:20 PM

Monday, August 24, 2020 4:11:20 PM

Post# of 424560
CEO of Hikma talk 'relevant' to our case - borrowed from Yahoo:

Thanks to Robert:

[Robert - 2 days ago

Was kind of surprised to read the CEO
of Hikma's snarky comments about JT.
He did admit a lower profit margin at first if they win the court case. As for their supply a couple clues in his comments.
"a supply ready " leaving out the word good or adequate to me suggests it might be small. And
"building the inventory " suggests it takes awhile just like JT has said.

Sigurdur Oli Olafsson, Hikma Pharmaceuticals PLC - CEO & Executive Director
" So I think, first of all, I'm a little bit different than the CEO of Amarin. So I don't comment on my expectation on the results of a judge. I think I'm not qualified in any way. I'm not a lawyer in any way. So for me to comment on that, I think, will be highly inappropriate to say the least. We're going to have the oral argument through phones on September 2. And we expect that the results could come as early as fourth quarter, maybe more likely in first quarter of next year, could be at the latest in the second quarter of next year. Also, it's interesting that the CEO of Amarin seems to know so much more than I do about the supply of the generics. And he also had a very deep understanding but we were surprised when the outcome of the legal case in Nevada, which he also commented. So I don't have the same understanding as he has. As I've said, I already have a supply ready to go to the market. If I would decide today, I could launch such risk. So we have a supply ready to launch at risk. We're also building the inventory to be able to take a fair market share in the market. But I'm not going to share with Amarin what my intended market share, that also depends on the other generics. If anyone else talked already, so anyone will be approved before the decision by the appeals court. So overall, I think on operating margin, what I've said, we expect a little bit lower margin in the beginning. We -- and we've been very open about that. But also we need to keep in mind that there is plenty of API suppliers today. When Amarin was originally developed this product, there was a limited supply. Where today, there's much more supply of the API than Amarin had in the beginning. So I think that is a very different situation. So -- but I can't comment on the thoughts that the CEO of Amarin has. It's just over and above my pay grade to do that. "/quote]

Surely Hikma CEO tries 'rub the judges on the back' - talking 'nonsense' about not talking about the case.

It would be 'strange' a small company fighting for it's life (generic thieves trying to steel their one product) - not talking about possible outcome of Appeal

Jasbg

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News